Last weeks announcement on “myocardial ischemia-reperfusion injury” put us north of 100 million over night. This condition has a treatment already proven but NYR are far superior. Safety this quarter is the main thing we need to prove up and this 4 billion dollar market for this indication NYR will dominate. 15 million market cap this is a joke but we will continue to rerate as safety gets ticked off this quarter
Walter Reed is what I’m looking forward that solidifies TBI
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
29.0¢ |
Change
-0.010(3.33%) |
Mkt cap ! $62.37M | |||
| Open | High | Low | Value | Volume |
| 30.0¢ | 30.0¢ | 29.0¢ | $207.0K | 700.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 75290 | 29.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.0¢ | 318267 | 3 |
View Market Depth
| Last trade - 11.00am 08/08/2025 (20 minute delay) ? |
| NYR (ASX) Chart |